Abstract
A rare complication in infants is an increased bleeding tendency. The incidence of bleeding in infants is not well known and depends very much on the age of gestation and which symptoms are considered. The human haemostatic system is dynamic and largely influenced by age. It is considered immature in the newborn, however it is a physiological system which results in few problems in the term neonate. In the preterm and sick neonate the haemostatic system can be largely out of balance and as a result cause a high bleeding tendency. Many of the procoagulants, anticoagulants and proteins involved in the haemostatic system are dependent on the age of gestation. The new-born’s haemostatic system matures in the weeks after delivery to become fully mature after 6 months. The preterm infant has much lower values, although they appear to normalise after delivery in the same 6 months period. It is important to realise this agedependent changes and for the most important coagulation tests and clotting factors they can be found in Table 1. Data on haemostatic values in healthy neonates are scarce, the data in this chapter originate from the studies performed by Dr Andrew [1],[2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrew M, Paes B, Milner R, et al. Development of the coagulation system in the full-term infant. Blood 1987;70:165–172.
Andrew M, Paes B, Milner R, et al. Development of the coagulation system in the pre-term infant. Blood 1988;80:1998–2005.
Goodnight Jr SH, Hathaway WE (eds). Disorders of hemostasis and thrombosis. A clinical guide. Second ed. New York: McGraw-Hill, 2001.
Williams MD. Guideline. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002;119:295–309.
Haemostasis and Thrombosis Task Force. Investigation and management of of haemorrhagic disorders in pregnancy. Clin Pathol 1994;47:100–108.
Andrew M, Vegh P, Caco C, et al. A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants. J Paediatr 1993;123:285–291.
Oh W, Fanaroff AA, Verter J, et al. Neonatal mortality and morbidity in very low birth weight infants; a seven year trend analysis of the Neonatal Network data. Paediatr Res 1996;39:235A.
Cornelissen M, Steegers-Theunissen R, Kollee R, et al. Increased incidence of neonatal vitamin K deficiency resulting form maternal anticonvulsant therapy. Am J Obstetr Gynaecol 1993;168:923–928.
Cornelissen M, von Kries R, Loughnan P, Schubiger G. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Paediatr 1997;156:126–130.
Ljung R, Tedgard U. Genetic counseling of hemophilia carriers. Semin Thromb Hemostasis 2003;29:31–36.
United Kingdom Haemophilia Centre Directors Organisation Executive Committee. Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia 1997;3:63–77.
Ljung, R, Sjorin E. Originof mutation in sporadic cases of haemophilia A. Br J Haematol 1999;106:870–874.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
van den Berg, H.M. (2005). The Bleeding Infant. In: Smit Sibinga, C.T., Luban, N. (eds) Neonatology and Blood Transfusion. Developments in Hematology and Immunology, vol 39. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-23600-1_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-23600-1_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23599-8
Online ISBN: 978-0-387-23600-1
eBook Packages: MedicineMedicine (R0)